CoA Reductase (statin) drugs for cholesterol lowering are known to inhibit the endogenous synthesis of CoQ10. CoQ10
supplementation can compensate for this inhibition ef ect and is indicated as a concurrent therapy when these drugs
are in use (100 mg of CoQ10 per day is recommended in these cases).